The Pharmacy Times® Mental Health Resource Center is a comprehensive resource for clinical news and expert insights on conditions that affect mood, thinking, and behavior, including clinical depression, bipolar disorder, schizophrenia, anxiety, and post-traumatic stress disorder.
May 7th 2024
The story of gepirone may spark new conversations for industry standards on drug development to facilitate future innovations.
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Eleven Potentially Practice-Changing Drugs Were Approved by the FDA in 2023
These drugs have interesting mechanisms, unique use, or may support expanded indications in the future.
Read More
MAPS PBC Submits NDA to the FDA for MDMA-Assisted Therapy for PTSD
December 12th 2023An FDA approval of 3,4-Methylenedioxy-methamphetamine (MDMA)–assisted therapy would require the Drug Enforcement Administration to reschedule MDMA in acknowledgement of its medical use, making it available for prescription medical use.
Read More
Psychedelic-Assisted Therapy: A Novel, Yet Effective Approach to Treating Mental Health Disorders
December 11th 2023By combining the administration of psychedelic compounds with therapeutic support, ketamine-assisted therapy is proving remarkable efficacy in treating mental health conditions.
Read More
Meeting the Challenges in Behavioral Health Care With Hybrid Pharmacy Approach
October 26th 2023The hybrid pharmacy model represents a significant step forward in providing the best possible care for individuals struggling with behavioral health conditions, ultimately improving their outcomes and overall well-being.
Read More